{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:44:53Z","timestamp":1774489493821,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ghir.2023.101536","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T23:44:00Z","timestamp":1684367040000},"page":"101536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Decreased insulin-like growth factor-1 expression in response to mechanical loading is associated with skeletal muscle anabolic resistance in cancer cachexia"],"prefix":"10.1016","volume":"69-70","author":[{"given":"Mitsunori","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ghir.2023.101536_bb0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10522-015-9631-7","article-title":"Live strong and prosper: the importance of skeletal muscle strength for healthy ageing","volume":"17","author":"McLeod","year":"2016","journal-title":"Biogerontology"},{"issue":"3","key":"10.1016\/j.ghir.2023.101536_bb0010","doi-asserted-by":"crossref","first-page":"E594","DOI":"10.1152\/ajpendo.00257.2016","article-title":"Control of skeletal muscle atrophy in response to disuse: clinical\/preclinical contentions and fallacies of evidence","volume":"311","author":"Atherton","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2023.101536_bb0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ghir.2023.101536_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and numbers","volume":"1","author":"von Haehling","year":"2010","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.ghir.2023.101536_bb0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMcibr1106880","article-title":"Cancer cachexia and fat-muscle physiology","volume":"365","author":"Fearon","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2023.101536_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/168407","article-title":"Inflammation based regulation of cancer cachexia","volume":"2014","author":"Onesti","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.ghir.2023.101536_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/bjc.2011.216","article-title":"Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF)","volume":"105","author":"Mirza","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ghir.2023.101536_bb0040","doi-asserted-by":"crossref","first-page":"26991","DOI":"10.1038\/srep26991","article-title":"Aerobic exercise and pharmacological treatments counteract cachexia by modulating autophagy in colon cancer","volume":"6","author":"Pigna","year":"2016","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.ghir.2023.101536_bb0045","first-page":"5568","article-title":"Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats","volume":"54","author":"Temparis","year":"1994","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ghir.2023.101536_bb0050","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ajpath.2012.12.023","article-title":"Autophagic degradation contributes to muscle wasting in cancer cachexia","volume":"182","author":"Penna","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.ghir.2023.101536_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13539-014-0141-2","article-title":"Modeling human cancer cachexia in colon 26 tumor-bearing adult mice","volume":"5","author":"Talbert","year":"2014","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"8","key":"10.1016\/j.ghir.2023.101536_bb0060","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/annonc\/mdu085","article-title":"Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force","volume":"25","author":"Aapro","year":"2014","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ghir.2023.101536_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/SPC.0000000000000241","article-title":"Practical multimodal care for cancer cachexia","volume":"10","author":"Maddocks","year":"2016","journal-title":"Curr. Opin. Support Palliat Care"},{"issue":"3","key":"10.1016\/j.ghir.2023.101536_bb0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","article-title":"Cancer cachexia: rationale for the MENAC (multimodal-exercise, nutrition and anti-inflammatory medication for Cachexia) trial","volume":"8","author":"Solheim","year":"2018","journal-title":"BMJ Support. Palliat. Care"},{"key":"10.1016\/j.ghir.2023.101536_bb0075","first-page":"CD010804","article-title":"Exercise for cancer cachexia in adults","volume":"3","author":"Grande","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.ghir.2023.101536_bb0080","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.metabol.2016.01.014","article-title":"Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia","volume":"65","author":"Khamoui","year":"2016","journal-title":"Metabolism"},{"issue":"16","key":"10.1016\/j.ghir.2023.101536_bb0085","article-title":"Voluntary exercise prevents abnormal muscle mitochondrial morphology in cancer cachexia mice","volume":"9","author":"Kitaoka","year":"2021","journal-title":"Phys. Rep."},{"issue":"11","key":"10.1016\/j.ghir.2023.101536_bb0090","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1249\/MSS.0000000000002393","article-title":"The effect of wheel exercise on functional indices of Cachexia in tumor-bearing mice","volume":"52","author":"Vanderveen","year":"2020","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.ghir.2023.101536_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101012","article-title":"Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2\/TRIP15\/ALIEN","volume":"39","author":"Alves","year":"2020","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2023.101536_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1249\/JES.0000000000000159","article-title":"Resistance exercise\u2019s ability to reverse cancer-induced anabolic resistance","volume":"46","author":"Montalvo","year":"2018","journal-title":"Exerc. Sport Sci. Rev."},{"issue":"6","key":"10.1016\/j.ghir.2023.101536_bb0105","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1152\/japplphysiol.00908.2019","article-title":"Repeated eccentric contractions positively regulate muscle oxidative metabolism and protein synthesis during cancer cachexia in mice","volume":"128","author":"Hardee","year":"2020","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"11","key":"10.1016\/j.ghir.2023.101536_bb0110","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1177\/0269215520941912","article-title":"Resistance training impact on mobility, muscle strength and lean mass in pancreatic cancer cachexia: a randomized controlled trial","volume":"34","author":"Kamel","year":"2020","journal-title":"Clin. Rehabil."},{"issue":"suppl_2","key":"10.1016\/j.ghir.2023.101536_bb0115","doi-asserted-by":"crossref","first-page":"ii10","DOI":"10.1093\/annonc\/mdx809","article-title":"Muscle protein anabolism in advanced cancer patients: response to protein and amino acids support, and to physical activity","volume":"29","author":"Antoun","year":"2018","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ghir.2023.101536_bb0120","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809910","article-title":"Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor","volume":"12","author":"Liva","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ghir.2023.101536_bb0125","doi-asserted-by":"crossref","first-page":"8018197","DOI":"10.1155\/2017\/8018197","article-title":"Linking cancer cachexia-induced anabolic resistance to skeletal muscle oxidative metabolism","volume":"2017","author":"Hardee","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.ghir.2023.101536_bb0130","first-page":"R741","article-title":"Akt1 deficiency diminishes skeletal muscle hypertrophy by reducing satellite cell proliferation","volume":"314","author":"Moriya","year":"2018","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.ghir.2023.101536_bb0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ghir.2023.101536_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ghir.2014.06.003","article-title":"Optimizing IGF-I for skeletal muscle therapeutics","volume":"24","author":"Philippou","year":"2014","journal-title":"Growth Hormon. IGF Res."},{"issue":"3","key":"10.1016\/j.ghir.2023.101536_bb0145","first-page":"R674","article-title":"IGF-1 is downregulated in experimental cancer cachexia","volume":"291","author":"Costelli","year":"2006","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"9","key":"10.1016\/j.ghir.2023.101536_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ghir.2023.101536_bb0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mus.23798","article-title":"Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patients","volume":"48","author":"Bonetto","year":"2013","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ghir.2023.101536_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<42::AID-CNCR5>3.0.CO;2-M","article-title":"Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover","volume":"82","author":"Dworzak","year":"1998","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ghir.2023.101536_bb0165","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.ghir.2023.101536_bb0170","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1096\/fj.11-192195","article-title":"Is functional hypertrophy and specific force coupled with the addition of myonuclei at the single muscle fiber level?","volume":"26","author":"Qaisar","year":"2012","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.ghir.2023.101536_bb0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/84839","article-title":"Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle","volume":"27","author":"Musaro","year":"2001","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ghir.2023.101536_bb0180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-020-00904-3","article-title":"Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy","volume":"13","author":"Hua","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.ghir.2023.101536_bb0185","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1470-2045(02)00731-3","article-title":"Insulin-like growth factors and cancer","volume":"3","author":"Furstenberger","year":"2002","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ghir.2023.101536_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3835(96)04197-3","article-title":"The lack of an effect by insulin or insulin-like growth factor-1 in attenuating colon-2-mediated cancer cachexia","volume":"103","author":"Lazarus","year":"1996","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.ghir.2023.101536_bb0195","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.25146","article-title":"Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?","volume":"127","author":"Penna","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ghir.2023.101536_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.ghir.2023.101536_bb0205","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.ghir.2023.101536_bb0210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/ard.2005.040816","article-title":"Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3","volume":"65","author":"Sarzi-Puttini","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ghir.2023.101536_bb0215","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41581-021-00498-0","article-title":"Pathophysiological mechanisms leading to muscle loss in chronic kidney disease","volume":"18","author":"Wang","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.ghir.2023.101536_bb0220","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0008-6363(02)00788-5","article-title":"High glucose induces cardiac insulin-like growth factor I resistance in ventricular myocytes: role of Akt and ERK activation","volume":"57","author":"Ren","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ghir.2023.101536_bb0225","doi-asserted-by":"crossref","first-page":"15201","DOI":"10.1038\/ncomms15201","article-title":"miR-29b contributes to multiple types of muscle atrophy","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ghir.2023.101536_bb0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biocel.2017.07.020","article-title":"miR-18a induces myotubes atrophy by down-regulating IgfI","volume":"90","author":"Liu","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.ghir.2023.101536_bb0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1152\/japplphysiol.00416.2015","article-title":"Eccentric contraction-induced myofiber growth in tumor-bearing mice","volume":"120","author":"Hardee","year":"2016","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"6","key":"10.1016\/j.ghir.2023.101536_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199050","article-title":"High-intensity eccentric training ameliorates muscle wasting in colon 26 tumor-bearing mice","volume":"13","author":"Tatebayashi","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ghir.2023.101536_bb0245","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jcsm.12232","article-title":"Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice","volume":"8","author":"Brown","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.ghir.2023.101536_bb0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcdb.2015.11.005","article-title":"The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting","volume":"54","author":"Carson","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.ghir.2023.101536_bb0255","doi-asserted-by":"crossref","first-page":"E1042","DOI":"10.1152\/ajpendo.00410.2012","article-title":"Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK","volume":"304","author":"White","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663742300014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663742300014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:53:05Z","timestamp":1761087185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109663742300014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":51,"alternative-id":["S109663742300014X"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2023.101536","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased insulin-like growth factor-1 expression in response to mechanical loading is associated with skeletal muscle anabolic resistance in cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2023.101536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101536"}}